<DOC>
	<DOCNO>NCT00445172</DOCNO>
	<brief_summary>The purpose study investigate safety efficacy long-term E0302 administration patient Amyotrophic Lateral Sclerosis ( ALS ) .</brief_summary>
	<brief_title>A Long-Term Study Patients With Amyotrophic Lateral Sclerosis ( ALS )</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>1 . Patients complete Phase II/III study E0302 ( E0302J081761 , hereafter refer Study 761 ) except patient discontinue treatment Study 761 . Completed patient define complete treatment period Study 761 , 24hour use noninvasive positive pressure ventilation ( NIPPV ) , eventually result use NIPPV . 2 . Patients able submit write informed consent . If patient duly capable study consent unable sign ( affix seal ) due aggravation disease condition , write informed consent obtain legally authorize representative sign behalf patient confirm patient ' agreement study participation . 1 . Patients cognitive impairment . 2 . Pregnant woman woman may possibility become pregnant . 3 . Patients partner willing use reliable contraception . 4 . Patients severe disease renal , cardiovascular , hematological , hepatic system ( severe disease judge refer `` Ministry Health , Labor Welfare ( MHLW ) Drug Safety Dept . Notification No . 80 , Drug Safety Classification Criteria Severity Adverse Drug Reaction Medicinal Products , Grade 3 . '' However , event due primary disease preclude ) . 5 . Patients malignant tumor . 6 . Patients participate another clinical study completion Study 761 . 7 . Patients present illness history drug allergy severe allergic disease ( anaphylactic shock ) . 8 . Patients judge ineligible study entry investigator subinvestigator .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Amyotrophic Lateral Sclerosis</keyword>
	<keyword>Motor Neurons</keyword>
	<keyword>Muscular Atrophy</keyword>
</DOC>